How has been the historical performance of Tulasee Bio-Eth.?

Nov 12 2025 11:22 PM IST
share
Share Via
Tulasee Bio-Eth. has reported zero net sales and operating income from Mar'19 to Mar'25, with negative operating profit and increasing total liabilities and debt. The company's financial health has declined, reflected in worsening reserves and stagnant cash flow.
Answer:
The historical performance of Tulasee Bio-Eth. shows consistent figures over the years, with no net sales or other operating income reported from Mar'19 to Mar'25. Total operating income has remained at zero for the same period, and all major expense categories, including raw material costs, employee costs, and manufacturing expenses, have also consistently reported zero. The only expense that has fluctuated slightly is "Other Expenses," which decreased from 0.57 Cr in Mar'21 to 0.13 Cr in Mar'25. Consequently, the operating profit (PBDIT) has been negative, with a loss of -0.13 Cr reported from Mar'23 to Mar'25, following a profit of 0.48 Cr in Mar'21 and Mar'20. Profit before tax and profit after tax have mirrored this trend, showing losses of -0.13 Cr in the last three years. The company's equity capital has remained stable at 5.84 Cr, while reserves have been negative, decreasing from -4.61 Cr in Mar'21 to -5.14 Cr in Mar'25. The total liabilities have increased slightly from 8.18 Cr in Mar'20 to 8.22 Cr in Mar'25, with total debt rising from 6.66 Cr to 7.38 Cr during the same period. Cash flow statements indicate no cash inflow or outflow across the years, reflecting a stagnant financial position.

Breakdown:
Tulasee Bio-Eth. has not generated any revenue or operating income from Mar'19 to Mar'25, with total operating income consistently at zero. The company has incurred minimal expenses, primarily in "Other Expenses," which have decreased over the years. Operating profit has been negative since Mar'22, with a loss of -0.13 Cr in the last three years, following a profit in the previous two years. The company's equity capital has remained unchanged, while reserves have worsened, indicating a decline in financial health. Total liabilities have seen a slight increase, with total debt rising steadily, reflecting a growing financial burden. The cash flow statements show no activity, highlighting a lack of operational movement or financial transactions during this period.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News